Torque Teno Virus plasma level as novel biomarker of retained immunocompetence in HIV-infected patients

PURPOSE: To predict the course of immune recovery (IR) in HIV-1-infected patients after initiation of combined antiretroviral therapy (cART) by determination of the plasma concentration of Torque Teno Virus (TTV). TTV has been identified as marker for risk assessment in immunosuppressed patients aft...

Descripción completa

Detalles Bibliográficos
Autores principales: Schmidt, L., Jensen, B.-E. O., Walker, A., Keitel-Anselmino, V., di Cristanziano, V., Böhm, M., Knops, E., Heger, E., Kaiser, R., de Luca, A., Oette, M., Häussinger, D., Timm, J., Fuchs, A., Lübke, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159784/
https://www.ncbi.nlm.nih.gov/pubmed/33537915
http://dx.doi.org/10.1007/s15010-020-01573-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159784/
https://www.ncbi.nlm.nih.gov/pubmed/33537915
http://dx.doi.org/10.1007/s15010-020-01573-7

Ejemplares similares